Skip to content

comparing effect of dexmedetomidine versus dexamethasone as an adjuvant with ropivacaine in blocks for thyroid surgeries

A comparative study of post operative analgesic efficacy of dexmedetomidine 50 mcg versus dexamethasone 4 mg used as an adjuvant with 20 ml 0.25% ropivacaine in bilateral superficial cervical plexus block for thyroidectomy under general anaesthesia - a prospective randomized double blinded study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033720
Enrollment
80
Registered
2021-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Injection dexmedetomidine as an adjuvant with injection ropivacaine in bilateral superficial cervical plexus block with general anaesthesia in thyroid surgeries.: Injection dexmedetom

Sponsors

JLN medical college Ajmer
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing thyroid surgery under general anaesthesia Patient age between 16 â?? 60 years ASA physical status I and II

Exclusion criteria

Exclusion criteria: Age 60 years ASA physical status III, IV, V and VI. Patientâ??s refusal. Patient with a known history of -sensitivity and contraindications to drugs used -chronic analgesic consumption -psychiatric illness Patients non-euthyroid at the time of surgery. Patients with known coagulopathy. Infection at the site of block. Patients with substernal goitre Patients with stridor or respiratory compromise Patients with thyroid malignancy requiring block dissection Patients having advanced heart block Patients with severe ventricular dysfunction, and/or hypovolemia Patients with co-mobidities like diabetes mellitus or chronic hypertension

Design outcomes

Primary

MeasureTime frame
Duration of postoperative analgesiaTimepoint: Around 1 year

Secondary

MeasureTime frame
total consumption of analgesic in 24 hour post operative nausea vomiting adverse effects like hematoma, intra vascular injection, local anaesthetic toxicity, bradycardia, hypotension, sedation and post operative respiratory distressTimepoint: Around 1 year

Countries

India

Contacts

Public ContactDr Neena Jain

JLN medical college, Ajmer

drneenaj@gmail.com9414008666

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026